Promotion of non-small cell lung cancer tumor growth by FHL2 via inducing angiogenesis and vascular permeability
Tengfei Chen,
Jun Chen,
Qiuyun Chen
et al.
Abstract:Background
Antiangiogenetic therapy is one of the effective strategies for non-small cell lung cancer (NSCLC) treatment. Four-and-a-half LIM-domain protein 2 (
FHL2
) serves as a key function in cell growth and metastasis of multiple cancers, but the role of
FHL2
in NSCLC angiogenesis has not been intensely examined.
Methods
FHL2
expression in NSCLC tissues and cell lines and its correlation with patie… Show more
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.